click enter text
call surpris initi stock reaction suggest
result light consum overshadow anticip strength
primescan/tech sale ebit margin clean ep beat
spite higher tax rate add concern highlight
wholesale/retail disconnect lab consum channel investor
appropri read pricing/inventori challeng guid
lsd organ quarter top comp price pressur consum
expect evid result see dilig
preview one key driver modest revenu forecast
prior consensu slower logic
time dsworld shift effect shift
growth all-told result guid littl alter
think model estim chang line
ep rais margin momentum remain peer perform
optimist bia rais pt look higher visibl
field action product line-up
detail revenu hardwar number solid
growth implant imag exhibit investor expect
upsid primescan strength primescan growth held back somewhat
manufactur capac geograph avail upsid
remain growth accret ex us approv come manag also
point competit promot activ lab product wholesal
purchas driven discount retail level competitor creat
fluctuat sale rel end custom demand
margin drive beat gross margin sg cost control better
expect off-set higher tax rate higher
expect share count drive ep beat vs consensu
quarter manag rais guidanc year higher
oper margin expect off-set addit fx pressur
higher full year tax rate model lower revenu estim
consum foreign exchang slightli slower primescan growth
forecast given suppli limit off-set higher oper
margin forecast drive ebit forecast higher tax
interest expens forecast lower sale forecast off-set
higher margin ep estim increas exhibit
trade fundament data
upsid target
report limit sole use client wolf research pleas refer disclosur section locat end
report analyst certif import disclosur disclosur
page
result wolf model chang
exhibit result vs wolf estimate consensu
exhibit price-to-earnings rel dental sector averag price-to-earnings
exhibit guidanc tracker outlook
page
bpstotal net bpstax bpsvarianc price-to-earnings premium dental averag median medianannu guidancea sale y/ybelow exp exp debt ebitdainvest grade util balanc sheet enhanc ep growthebit end end restructur save portfolio shape continu plan margin expans growthdoubl digit acceler ep growth near-term cost save realizedrevenu consum growth steadi return growth thereaft new product introduct invest global scale faster grow region overal growth dental
exhibit organ revenu growth adjust inventori
exhibit organ revenu bridg adjust inventori chang
exhibit organ revenu trend region product line
page
page
page
yieldfcf compound-annual-growth-rate ebitda compound-annual-growth-rate ev-ebitda vs estimate ebitda compound-annual-growth-rate tool ntm price-to-earnings ratio median price-to-earnings premium compound-annual-growth-rate
note figur million unless state per-shar term
page
metal margin inc tax unconsolid net non incom net cont dilut non margin
note figur million unless state per-shar term
page
